Net income (loss) per share attributable to common stockholders was computed as follows:


	Three Months Ended March 31,
	2026		2025
Numerator:
Net income (loss) attributable to Hippo – basic and diluted (in millions)	$	7.1	$	(47.7)
Denominator:
Weighted-average shares used in computing net income (loss) per share attributable to Hippo
Basic	25,840,004		24,978,901
Diluted	26,354,271		24,978,901
Net income (loss) per share attributable to Hippo
Basic	$	0.27	$	(1.91)
Diluted	$	0.27	$	(1.91)

The potential shares of common stock that were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows:


	March 31,
	2026	2025

Outstanding options	—	1,076,791
Common stock from outstanding warrants	360,000	360,000

Common stock subject to repurchase	—	—
RSU and PRSUs	11,732	2,243,551
Employee stock purchase plan	18,205	—

Total	389,937	3,680,342